Unither Pharmaceuticals is a pharmaceutical subcontractor that specialises in the development and manufacturing of single-dose and multidose liquid formulations, such as eye drops, saline solutions, asthma medications in BFS single doses, and oral liquid stick-packs. The company serves originator pharmaceutical companies and generic manufacturers, boasting a workforce of 2,200 employees across eight manufacturing plants located in France, the United States, Brazil, and China. In 2023, Unither Pharmaceuticals reported sales of €475 million.

Services include:
– Biologics
– Medical Devices
– Research & Development
– Packaging
– Regulatory Services
– Analytical Methods Development

Unither Pharmaceuticals is committed to delivering high-quality pharmaceutical solutions to its clients, ensuring compliance with industry standards and advancing the field through innovative practices. For more information, visit unither.com.